Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure

CMAJ. Canadian Medical Association Journal

Volumn 178, Issue 10, 2008, Pages 1303-1311

  Pilote, Louise ^a,f   Abrahamowicz, Michal ^a,b   Eisenberg, Mark ^c   Humphries, Karin ^d   Behlouli, Hassan ^a   Tu, Jack V ^e  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; LISINOPRIL; PERINDOPRIL; QUINAPRIL; RAMIPRIL;

AGED; ARTICLE; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; DEMOGRAPHY; DRUG EFFECT; FEMALE; HAZARD RATIO; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCRIPTION; PROPORTIONAL HAZARDS MODEL;

EID: 43549097097     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.060068     Document Type: Article

References (35)